It had been shown before in the 3xTg-AD mouse model that antitau immunotherapy or passive anti-Aβ immunotherapy led to removal of tau or Aβ or both [19, 43, 55, 61–64]. This evidence concerns the gene MAPT and Alzheimer disease.